Cargando…

METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing

BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various pathological processes. However, the role of m6A RNA modifica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaotong, Wang, Jing, Zhao, Xibo, Wu, Han, Li, Jixin, Cheng, Yan, Guo, Qiuyan, Cao, Xuejiao, Liang, Tian, Sun, Liyuan, Zhang, Guangmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288727/
https://www.ncbi.nlm.nih.gov/pubmed/37353804
http://dx.doi.org/10.1186/s12967-023-04209-0
_version_ 1785062131453919232
author Wang, Xiaotong
Wang, Jing
Zhao, Xibo
Wu, Han
Li, Jixin
Cheng, Yan
Guo, Qiuyan
Cao, Xuejiao
Liang, Tian
Sun, Liyuan
Zhang, Guangmei
author_facet Wang, Xiaotong
Wang, Jing
Zhao, Xibo
Wu, Han
Li, Jixin
Cheng, Yan
Guo, Qiuyan
Cao, Xuejiao
Liang, Tian
Sun, Liyuan
Zhang, Guangmei
author_sort Wang, Xiaotong
collection PubMed
description BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various pathological processes. However, the role of m6A RNA modification in endometriosis remains unclear. The present study explores METTL3-mediated m6A modification and the mechanisms involved in endometriosis. METHODS: The dominant m6A regulators in EMs were analysed using RT‒PCR. Candidate targets and possible mechanisms of METTL3 were assessed by m6A-mRNA epitranscriptomic microarray and RNA sequencing. A primary ESCs model was employed to verify the effect of METTL3 on m6A modification of SIRT1 mRNA, and the mechanism was elucidated by RT‒PCR, Western blotting, MeRIP, and RIP assays. CCK-8 viability assays, Transwell invasion assays, EdU proliferation assays, wound healing migration assays, and senescence-associated β-galactosidase staining were performed to illuminate the potential biological mechanism of METTL3 and SIRT1 in ESCs in vitro. An in vivo PgrCre/ + METTL3 −/− female homozygous mouse model and a nude mouse xenograft model were employed to further investigate the physiologic consequences of METTL3-mediated m6A alteration on EMs. RESULTS: Our data show that decreased METTL3 expression significantly downregulates m6A RNA methylation levels in ESCs. Silencing m6A modifications mediated by METTL3 accelerates ESCs viability, proliferation, migration, and invasion in vitro. The m6A reader protein YTHDF2 binds to m6A modifications to induce the degradation of SIRT1 mRNA. SIRT1/FOXO3a signalling pathway activation is subsequently inhibited, promoting the cellular senescence of ESCs and inhibiting the ectopic implantation of ESCs in vitro and in vivo. CONCLUSIONS: Our findings demonstrate that METTL3-mediated m6A methylation epigenetically regulates the ectopic implantation of ESCs, resulting in the progression of endometriosis. Our study establishes METTL3-YTHDF2-SIRT1/FOXO3a as a critical axis and potential mechanism in endometriosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04209-0.
format Online
Article
Text
id pubmed-10288727
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102887272023-06-24 METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing Wang, Xiaotong Wang, Jing Zhao, Xibo Wu, Han Li, Jixin Cheng, Yan Guo, Qiuyan Cao, Xuejiao Liang, Tian Sun, Liyuan Zhang, Guangmei J Transl Med Research BACKGROUND: Endometriosis (EMs), the ectopic planting of functional endometrium outside of the uterus, is a leading cause of infertility and pelvic pain. As a fundamental mRNA modification, N6-methyladenosine (m6A) participates in various pathological processes. However, the role of m6A RNA modification in endometriosis remains unclear. The present study explores METTL3-mediated m6A modification and the mechanisms involved in endometriosis. METHODS: The dominant m6A regulators in EMs were analysed using RT‒PCR. Candidate targets and possible mechanisms of METTL3 were assessed by m6A-mRNA epitranscriptomic microarray and RNA sequencing. A primary ESCs model was employed to verify the effect of METTL3 on m6A modification of SIRT1 mRNA, and the mechanism was elucidated by RT‒PCR, Western blotting, MeRIP, and RIP assays. CCK-8 viability assays, Transwell invasion assays, EdU proliferation assays, wound healing migration assays, and senescence-associated β-galactosidase staining were performed to illuminate the potential biological mechanism of METTL3 and SIRT1 in ESCs in vitro. An in vivo PgrCre/ + METTL3 −/− female homozygous mouse model and a nude mouse xenograft model were employed to further investigate the physiologic consequences of METTL3-mediated m6A alteration on EMs. RESULTS: Our data show that decreased METTL3 expression significantly downregulates m6A RNA methylation levels in ESCs. Silencing m6A modifications mediated by METTL3 accelerates ESCs viability, proliferation, migration, and invasion in vitro. The m6A reader protein YTHDF2 binds to m6A modifications to induce the degradation of SIRT1 mRNA. SIRT1/FOXO3a signalling pathway activation is subsequently inhibited, promoting the cellular senescence of ESCs and inhibiting the ectopic implantation of ESCs in vitro and in vivo. CONCLUSIONS: Our findings demonstrate that METTL3-mediated m6A methylation epigenetically regulates the ectopic implantation of ESCs, resulting in the progression of endometriosis. Our study establishes METTL3-YTHDF2-SIRT1/FOXO3a as a critical axis and potential mechanism in endometriosis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-023-04209-0. BioMed Central 2023-06-23 /pmc/articles/PMC10288727/ /pubmed/37353804 http://dx.doi.org/10.1186/s12967-023-04209-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Xiaotong
Wang, Jing
Zhao, Xibo
Wu, Han
Li, Jixin
Cheng, Yan
Guo, Qiuyan
Cao, Xuejiao
Liang, Tian
Sun, Liyuan
Zhang, Guangmei
METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title_full METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title_fullStr METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title_full_unstemmed METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title_short METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing
title_sort mettl3-mediated m6a modification of sirt1 mrna inhibits progression of endometriosis by cellular senescence enhancing
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288727/
https://www.ncbi.nlm.nih.gov/pubmed/37353804
http://dx.doi.org/10.1186/s12967-023-04209-0
work_keys_str_mv AT wangxiaotong mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT wangjing mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT zhaoxibo mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT wuhan mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT lijixin mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT chengyan mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT guoqiuyan mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT caoxuejiao mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT liangtian mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT sunliyuan mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing
AT zhangguangmei mettl3mediatedm6amodificationofsirt1mrnainhibitsprogressionofendometriosisbycellularsenescenceenhancing